Sun Pharma Rises 2% on Acquiring Opiates Business in Australia

Sun Pharma shares jumped nearly 2 per cent to hit intraday high of Rs 915.30 after the company said that it successfully acquired GSK's opiates facilities in Australia. Sun Pharma in an announcement said that it acquired GSK's two opiates manufacturing facilities in Port Fairy and Latrobe in Australia.  The opiates expansion allows Sun Pharma to significantly expand its narcotics raw material (NRM) market share. It will enhance opi...